Effect of Cumulating Exposure to Abacavir on the Risk of Cardiovascular Disease Events in Patients From the Swiss HIV Cohort Study.

Abstract

BACKGROUND Patients with HIV exposed to the antiretroviral drug abacavir may have an increased risk of cardiovascular disease (CVD). There is concern that this association arises because of a channeling bias. Even if exposure is a risk, it is not clear how that risk changes as exposure cumulates. METHODS We assess the effect of exposure to abacavir on the… (More)
DOI: 10.1097/QAI.0000000000000662

Topics

5 Figures and Tables

Cite this paper

@article{Young2015EffectOC, title={Effect of Cumulating Exposure to Abacavir on the Risk of Cardiovascular Disease Events in Patients From the Swiss HIV Cohort Study.}, author={James Young and Yongling Xiao and Erica Moodie and Michal Abrahamowicz and Marina B Klein and Enos Bernasconi and Patrick Schmid and Alexandra L Calmy and Matthias Cavassini and Alexia Cusini and Rainer Weber and Heiner C. Bucher}, journal={Journal of acquired immune deficiency syndromes}, year={2015}, volume={69 4}, pages={413-21} }